Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature

Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of hematologic malignancies which typically respond to standard first-line chemoimmunotherapy regimens. Unfortunately, patients with refractory NHL face a poor prognosis and represent an unmet need for improved therapeutics. We present two cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Delacruz, Wilfred, Setlik, Robert, Hassantoufighi, Arash, Daya, Shyam, Cooper, Susannah, Selby, Dale, Brown, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078781/
https://www.ncbi.nlm.nih.gov/pubmed/27807492
http://dx.doi.org/10.1155/2016/2596423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078781/
https://www.ncbi.nlm.nih.gov/pubmed/27807492
http://dx.doi.org/10.1155/2016/2596423

Ejemplares similares